Cell therapy is a promising option for the treatment of ischemic diseases. Infusion or injection of stem or progenitor cells has improved neovascularization and heart function after ischemia in ...

Several observations from preclinical and short-term clinical studies support a role for sildenafil in the treatment of heart failure patients. The following discussion briefly considers each of ...

The prognosis (predicted outcome) for ischemic cardiomyopathy depends on how severely damaged the heart is and whether treatment can help stabilize or even reverse the damage. If you have been ...

Incidence of Ischemic Heart Disease According to Diagnostic Manifestation — Forty-four Months' Experience. Hypertensive disease, uncomplicated, was diagnosed when only a casual sphygmomanometric ...

Ischemic heart disease is the most common cause of death ... Depending on the symptoms and risk, treatment may be with medication, percutaneous coronary intervention (angioplasty) or coronary ...

People may experience hair loss for various reasons—perimenopause, chemotherapy, alopecia and more. It’s also normal to find ...

Researchers suggest an application to FDA may be made within the next 12 months, requesting approval to carry out a human clinical trial with the gene therapy.

A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model.

The following is a summary of “Optimising the treatment of chronic ischemic heart disease by training general practitioners to deliver very brief advice on physical activity (OptiCor): protocol of the ...

Mesoblast (MESO) has released an update. Mesoblast’s allogeneic cell therapy, Revascor, has shown promising results in ...

Mesoblast Limited (AU:MSB) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - ...